General Archive

Home » Our science
  • LifeArc collaboration helps to advance a potential new cancer drug towards the clinic

    Making our unique ULK inhibitors available as tools for the academic community has helped to reignite interest in blocking autophagy…

    Read more

  • Scientists in conversation

    Exploring new approaches to drug discovery

    LifeArc’s scientists have been working on a fresh approach to drug discovery, using a parallel high-throughput application to significantly improve…

    Read more

  • Rising to the challenge of COVID-19

    While the development of COVID-19 vaccines has garnered much attention, scientists have also been looking at repurposed medicines as an…

    Read more

  • How to kill a virus: LifeArc’s role in shaping the UK’s COVID-19 response

    In 2020 the UK Government, supported by UK Research and Innovation and the National Institute for Health and Research, launched…

    Read more

  • LifeArc scientists play pivotal role in the search for a COVID-19 antibody therapy

    While much attention in the race for treatments for Covid-19 has been on the development of new vaccines, scientists have…

    Read more

  • Virtual reality technology for small molecular drug discovery

    A project by an industrial placement student led to Virtual Reality becoming a powerful tool for drug discovery Technology has…

    Read more

  • Ecoli under the microscope

    Life, re-engineered: new milestone in the emerging field of synthetic genomics

    When MRC researchers achieved a new milestone in the emerging field of synthetic genomics, LifeArc set this early-stage technology on…

    Read more

  • Modelling the human brain

    Candidate drugs to treat the central nervous system could be screened with three-dimensional brain tissue grown in the laboratory. We…

    Read more

  • antibody, immunoglobulins, 3d rendering - Illustration

    Keytruda: a new generation of cancer treatment

    In 2007, LifeArc entered a collaboration with Organon – ultimately acquired by Merck – to translate innovative drug targets into…

    Read more

  • Cancer: LifeArc is working in partnership with Worldwide Cancer Research

    We have worked in partnership with Worldwide Cancer Research (WCR) since 2011 to ensure that intellectual property arising from their…

    Read more

  • Breast cancer: new treatment monitoring test avoids risks from biopsy

    Through their shared dedication to patients, LifeArc and diagnostics company Biocartis are developing a ‘liquid biopsy’ test for breast cancer…

    Read more

  • Renishaw Diagnostics: a test for antibiotic resistance

    We collaborated with Renishaw Diagnostics Ltd. on a rapid diagnostic test for the detection of carbapenemase genes, which are associated…

    Read more

WordPress development by Andy White using PorterWP